✦ LIBER ✦

Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults

✍ Scribed by S. J. Szefler; W. F. Ebling; J. W. Georgitis; W. J. Jusko

Publisher: Springer
Year: 1986
Tongue: English
Weight: 873 KB
Volume: 30
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00541537

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of prednisolone in norm

Pharmacokinetics of prednisolone in normal and asthmatic subjects in relation to dose

✍ W. A. C. McAllister; C. R. Winfield; J. V. Collins 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 538 KB

Pharmacokinetics of nocloprost in human

Pharmacokinetics of nocloprost in human volunteers and its relation to dose

✍ U. Täuber; M. Brudny-Klöppel; U. Jakobs; C. Madetzki; M. Mahler 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 409 KB

Pharmacokinetics of high-dose busulphan

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

✍ M. Hassan; G. Öberg; A. N. Bekassy; J. Aschan; H. Ehrsson; P. Ljungman; G. Lönne 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 532 KB

Multiple-dose pharmacokinetics and bioeq

Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers

✍ Chandrahas G. Sahajwalla; Edward D. Helton; Edward D. Purich; Charles L. Hoppel; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 955 KB

Severe embryolethality of artesunate rel

Severe embryolethality of artesunate related to pharmacokinetics following intravenous and intramuscular doses in pregnant rats

✍ Qigui Li; Yuanzheng Si; Lisa Xie; Jing Zhang; Peter Weina 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Dose-dependent pharmacokinetics of toxic

Dose-dependent pharmacokinetics of toxic metabolites is not related to increased toxicity following high-dose valproic acid in rats

✍ Byung Hwa Jung; Bo Jun Kim; Min Sun Lee; Joo Hyun Lee; Ju-Hee Oh; Young-Joo Lee 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

## Abstract It has been reported that urinary excretion of two metabolites of valproic acid (VPA), 4‐ene‐valproic acid (4‐VPA) and 2,4‐diene‐valproic acid (2,4‐VPA), increased exponentially with the administration of high doses of VPA, and this increased formation of toxic metabolites could be rela